Drug
Modified Release Dosage Form clinical trials
- studies test it
- 4
- open now
- 1
- in phase 3
- 4
- first study started
- 2003
Keep track of what changes. Save the Modified Release Dosage Form studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Combined with it in one product
- MR4
- 1
Studies by the year they started
4 studies that test it; most in 2007 (2)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2007 | 2 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 1
- Phase 3
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 1
Shire (1) · Astellas Pharma Inc (1) · Sanofi (1) · Leiden University Medical Center (1)
Often tested with
Tested in the same studies.
Tacrolimus (1) · Zolpidem (1) · Pyridostigmine (1) · Amifampridine (1)
Studies
Open first, then newest update. How each study uses Modified Release Dosage Form is read from its arms, and is right about nine times in ten.
Testing it · 4
- Pyridostigmine and Amifampridine for Myasthenia GravisRecruitingPhase 3Leiden University Medical CenterNCT05919407Written as Amifampridine (base) with modified release
- Once-daily Oral Modified Release Hydrocortisone in Patients With Adrenal InsufficiencyCompletedPhase 2/3ShireNCT00915343Written as hydrocortisone (modified release), oral tablet 20 and 5 mg
- An Open Study Assessing Bioavailability of a Modified Formulation of Tacrolimus in Kidney Transplant RecipientsCompletedPhase 3Astellas Pharma IncNCT00865137Written as Tacrolimus, modified release
- Evaluation of the Hypnotic Properties of Zolpidem-MR 12.5 mg and Zolpidem 10 mg Marketed Product Compared to Placebo in Patients With Primary InsomniaCompletedPhase 3SanofiNCT00630175Written as zolpidem-MR (modified release)